Spatial analysis of case-mix and dialysis modality associations

Peritoneal Dialysis International

Volumn 36, Issue 3, 2016, Pages 326-333

  Phirtskhalaishvili, Tamar ^a,b   Bayer, Florian ^a   Edet, Stephane ^c   Bongiovanni, Isabelle ^d   Hogan, Julien ^a,e   Couchoud, Cécile ^a  

^a AGENCE DE LA BIOMÉDECINE   (France)

^b Children s Medical Centre Mrcheveli   (Georgia)

^c Geriatrics Department   (France)

^d Ancien Délégué Général de la Fédération de l'Hospitalisation Privée   (France)

^e HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Agglomerative hierarchical cluster analysis; Case mix; Health care planning; Hemodialysis; Peritoneal dialysis

Indexed keywords

ADULT; AGED; ARTICLE; AUTOMATED PERITONEAL DIALYSIS; CARDIOVASCULAR DISEASE; CASE MIX; CLUSTER ANALYSIS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIALYSIS; END STAGE RENAL DISEASE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT AUTONOMY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SELF CARE; SPATIAL ANALYSIS; VERY ELDERLY; YOUNG ADULT; ADOLESCENT; DIAGNOSIS RELATED GROUP; FRANCE; HEMODIALYSIS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS-RELATED GROUPS; FEMALE; FRANCE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SELF CARE; SPATIAL ANALYSIS; YOUNG ADULT;

EID: 84969981031     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2015.00003     Document Type: Article

References (38)

1. ERA EDTA registry. ERA-EDTA Registry Annual Report 2011. Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands, 2013; 2013.
2. REIN registry. Rapport annuel REIN 2012. http://www.agence-biomedecine.fr/Le-programme-REIN; 2014.
3. Couchoud C, Savoye E, Frimat L, Ryckelynck JP, Chalem Y, Verger C. Variability in case mix and peritoneal dialysis selection in fifty-nine French districts. Perit Dial Int 2008; 28(5):509-17.
4. Bouvier N, Durand PY, Testa A, Albert C, Planquois V, Ryckelynck JP, et al. Regional discrepancies in peritoneal dialysis utilization in France: the role of the nephrologist’s opinion about peritoneal dialysis. Nephrol Dial Transplant 2009; 24(4):1293-7.
5. Couchoud C, Stengel B, Landais P, Aldigier JC, de Cornelissen F, Dabot C, et al. The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France. Nephrol Dial Transplant 2006; 21(2):411-8.
6. Benzécri JP. Correspondence analysis handbook. New York: Marcel Dekker, Inc., 1992.
7. Moran WP, Zhang J, Gebregziabher M, Brownfield EL, Davis KS, Schreiner AD, et al. Chaos to complexity: leveling the playing field for measuring value in primary care. J Eval Clin Pract 2015 [epub ahead of print].
8. Clatworthy J, Buick D, Hankins M, Weinman J, Horne R. The use and reporting of cluster analysis in health psychology: a review. Br J Health Psychol 2005; 10(Pt 3):329-58.
9. Alonso-Moran E, Orueta JF, Esteban JI, Axpe JM, Gonzalez ML, Polanco NT, et al. Multimorbidity in people with type 2 diabetes in the Basque Country (Spain): Prevalence, comorbidity clusters and comparison with other chronic patients. Eur J Intern Med 2015; 26(3):197-202.
10. Lobbedez T, Moldovan R, Lecame M, Hurault de LB, El Haggan W, Ryckelynck JP. Assisted peritoneal dialysis. Experience in a French renal department. Perit Dial Int 2006; 26(6):671-6.
11. Castrale C, Evans D, Verger C, Fabre E, Aguilera D, Ryckelynck JP, et al. Peritoneal dialysis in elderly patients: report from the French Peritoneal Dialysis Registry (RDPLF). Nephrol Dial Transplant 2010; 25(1):255-62.
12. Genestier S, Meyer N, Chantrel F, Alenabi F, Brignon P, Maaz M, et al. Prognostic survival factors in elderly renal failure patients treated with peritoneal dialysis: a nine-year retrospective study. Perit Dial Int 2010; 30(2):218-26.
13. Biesenbach G, Pohanka E. Dialysis in diabetic patients: hemodialysis and peritoneal dialysis. Pros and cons. Minerva Urol Nefrol 2012; 64(3):173-82.
14. Locatelli F, Pozzoni P, Del Vecchio L. Renal replacement therapy in patients with diabetes and end-stage renal disease. J Am Soc Nephrol 2004; 15(Suppl 1):S25-9.
15. Van LS, Veys N, Verbeke F, Vanholder R, Van BW. The fate of older diabetic patients on peritoneal dialysis: myths and mysteries and suggestions for further research. Perit Dial Int 2007; 27(6):611-8.
16. Unal A, Hayri SM, Kocyigit I, Elmali F, Tokgoz B, Oymak O. Does body mass index affect survival and technique failure in patients undergoing peritoneal dialysis? Pak J Med Sci 2014; 30(1):41-4.
17. Couchoud C, Bolignano D, Nistor I, Jager KJ, Heaf J, Heimburger O, et al. Dialysis modality choice in diabetic patients with end-stage kidney disease: a systematic review of the available evidence. Nephrol Dial Transplant 2014; 30(2):310-20.
18. Nunez J, Gonzalez M, Minana G, Garcia-Ramon R, Sanchis J, Bodi V, et al. Continuous ambulatory peritoneal dialysis and clinical outcomes in patients with refractory congestive heart failure. Rev Esp Cardiol (Engl Ed) 2012; 65(11):986-95.
19. Gotloib L, Fudin R, Yakubovich M, Vienken J. Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation. Nephrol Dial Transplant 2005; 20(Suppl 7):vii32-6.
20. Sens F, Schott-Pethelaz AM, Labeeuw M, Colin C, Villar E. Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure. Kidney Int 2011; 80(9):970-7.
21. Miskulin DC, Meyer KB, Athienites NV, Martin AA, Terrin N, Marsh JV, et al. Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. Am J Kidney Dis 2002; 39(2):324-36.
22. Chanouzas D, Ng KP, Fallouh B, Baharani J. What influences patient choice of treatment modality at the pre-dialysis stage? Nephrol Dial Transplant 2012; 27(4):1542-7.
23. Harwood L, Clark AM. Understanding pre-dialysis modality decision-making: a meta-synthesis of qualitative studies. Int J Nurs Stud 2013; 50(1):109-20.
24. Just PM, de Charro FT, Tschosik EA, Noe LL, Bhattacharyya SK, Riella MC. Reimbursement and economic factors influencing dialysis modality choice around the world. Nephrol Dial Transplant 2008; 23(7):2365-73.
25. Palmer SC, de BG, Craig JC, Tong A, Tonelli M, Pellegrini F, et al. Patient satisfaction with in-centre haemodialysis care: an international survey. BMJ Open 2014; 4(5):e005020.
26. Maaroufi A, Fafin C, Mougel S, Favre G, Seitz-Polski B, Jeribi A, et al. Patients’ preference regarding choice of end-stage renal disease treatment options. Am J Nephrol 2013; 37(4):359-69.
27. Goovaerts T, Jadoul M, Goffin E. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy. Nephrol Dial Transplant 2005; 20(9):1842-7.
28. Ribitsch W, Haditsch B, Otto R, Schilcher G, Quehenberger F, Roob JM, et al. Effects of a pre-dialysis patient education program on the relative frequencies of dialysis modalities. Perit Dial Int 2013; 33(4):367-71.
29. Just PM, Riella MC, Tschosik EA, Noe LL, Bhattacharyya SK, de Charro F. Economic evaluations of dialysis treatment modalities. Health Policy 2008; 86(2-3):163-80.
30. Blotiere PO, Tuppin P, Weill A, Ricordeau P, Allemand H. The cost of dialysis and kidney transplantation in France in 2007, impact of an increase of peritoneal dialysis and transplantation. Nephrol Ther 2010; 6(4):240-7.
31. U S Renal Data System. USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States; 2012.
32. Cleemput I, Beguin Cl, De la Kethulle Y, Gerkens S, Jadoul M, Verpooten G, et al. Organisation et financement de la dialyse chronique en Belgique. KCE reports 124B. Bruxelles: Centre fédéral d’expertise des soins de santé; 2010.
33. McFarlane PA. Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada. Semin Dial 2004; 17(2):118-24.
34. Mowatt G, Vale L, Perez J, Wyness L, Fraser C, Macleod A, et al. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure. Health Technol Assess 2003; 7(2):1-174.
35. Winkelmayer WC, Weinstein MC, Mittleman MA, Glynn RJ, Pliskin JS. Health economic evaluations: the special case of end-stage renal disease treatment. Med Decis Making 2002; 22(5):417-30.
36. Couchoud C, Dantony E, Elsensohn MH, Villar E, Ecochard R, REIN Registry. Modelling treatment trajectories to optimize the organization of renal replacement therapy and public health decision-making. Nephrol Dial Transplant 2013; 28(9):2372-82.
37. Couchoud C, Couillerot AL, Dantony E, Elsensohn MH, Labeeuw M, Villar E, et al. Economic impact of a modification of the treatment trajectories of patients with end-stage renal disease. Nephrol Dial Transplant 2015 [epub ahead of print].
38. Plantinga LC, Fink NE, Finkelstein FO, Powe NR, Jaar BG. Association of peritoneal dialysis clinic size with clinical outcomes. Perit Dial Int 2009; 29(3):285-91.